
Mayo Clinic researchers have identified a diverse range of environmental chemicals in human bile in patients with primary sclerosing cholangitis, a rare, chronic liver disease of the bile ducts. The study, published in Exposome, represents a new frontier of research at Mayo Clinic's Center for Individualized Medicine that explores the exposome, the measure of environmental contributors to disease and health.
Most people with primary sclerosing cholangitis also have some type of inflammatory bowel disease, such as ulcerative colitis or Crohn's disease, often leading to end-stage liver disease and cancer. Liver transplantation is the only evidence-based treatment for this advanced disease and no drug therapy exists to improve survival without a transplant.
"We know patients with this complex bile duct disorder have an altered metabolome (the complete set of small-molecule chemicals found within a biological sample), which environmental chemicals may influence," says Mayo Clinic researcher Konstantinos N. Lazaridis, M.D., the Carlson and Nelson Endowed Executive Director for Mayo Clinic's Center for Individualized Medicine. "Now we have a comprehensive exposome characterization of bile, which is critical, as bile directly comes into contact with diseased bile ducts."
Dr. Lazaridis notes that this could contribute to higher absorption of environmental chemicals for patients with primary sclerosing cholangitis who also have inflammatory bowel disease.
This liver disease likely develops from genetic and environmental factors. Understanding the contribution of environmental exposures to this disease could lead to discoveries about its causes and risk factors.
For the study, researchers investigated bile samples from patients with the disease using high-resolution mass spectrometry and found various environmental chemicals. This new technology allowed researchers to measure and analyze external chemical exposures and their biological responses, with enough coverage to study the relationships between potential disease drivers and their effects.
The researchers assessed these similarities and differences in the bile of patients in the U.S. versus Norway.
"The findings of the derived chemical-metabolomic links in the bile serve as a starting point," says Dr. Lazaridis. "They are essential in understanding the biochemical changes that happen with environmental chemical exposure, as they may reflect the cause and progression of primary sclerosing cholangitis and may lead to new medical therapies."
This article originally appeared on the Mayo Clinic Individualized Medicine blog.
Mayo Clinic researchers studying the genetics of people who had recently developed dilated cardiomyopathy, one of the most common causes of heart failure, have found a ...
During breaks from his doctoral research in London, Richard Vile, Ph.D., would visit a pediatric brain tumor clinic next to his lab for inspiration. Seeing children ...
A recent Mayo Clinic retrospective study shows that cancer practices can integrate telehealth without duplicative care, allowing for a more streamlined healthcare experience for patients and their ...